Free Trial

Alvotech (ALVO) Competitors

Alvotech logo
$8.72 -0.03 (-0.34%)
Closing price 10/17/2025 04:00 PM Eastern
Extended Trading
$8.76 +0.04 (+0.52%)
As of 10/17/2025 07:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ALVO vs. ELAN, VRNA, RVMD, ABVX, RNA, CYTK, MRUS, RYTM, CRSP, and GRFS

Should you be buying Alvotech stock or one of its competitors? The main competitors of Alvotech include Elanco Animal Health (ELAN), Verona Pharma PLC American Depositary Share (VRNA), Revolution Medicines (RVMD), Abivax (ABVX), Avidity Biosciences (RNA), Cytokinetics (CYTK), Merus (MRUS), Rhythm Pharmaceuticals (RYTM), CRISPR Therapeutics (CRSP), and Grifols (GRFS). These companies are all part of the "pharmaceutical products" industry.

Alvotech vs. Its Competitors

Alvotech (NASDAQ:ALVO) and Elanco Animal Health (NYSE:ELAN) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment.

Alvotech has a beta of 0.1, suggesting that its share price is 90% less volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.65, suggesting that its share price is 65% more volatile than the S&P 500.

Alvotech presently has a consensus price target of $14.00, indicating a potential upside of 60.55%. Elanco Animal Health has a consensus price target of $19.14, indicating a potential downside of 10.65%. Given Alvotech's higher possible upside, equities research analysts plainly believe Alvotech is more favorable than Elanco Animal Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alvotech
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.80
Elanco Animal Health
0 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
2.91

In the previous week, Elanco Animal Health had 1 more articles in the media than Alvotech. MarketBeat recorded 8 mentions for Elanco Animal Health and 7 mentions for Alvotech. Alvotech's average media sentiment score of 0.77 beat Elanco Animal Health's score of 0.64 indicating that Alvotech is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alvotech
2 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Elanco Animal Health
3 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Elanco Animal Health has higher revenue and earnings than Alvotech. Elanco Animal Health is trading at a lower price-to-earnings ratio than Alvotech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$491.98M5.34-$231.86M$0.2337.91
Elanco Animal Health$4.48B2.37$338M$0.8624.91

97.5% of Elanco Animal Health shares are owned by institutional investors. 0.5% of Alvotech shares are owned by company insiders. Comparatively, 0.9% of Elanco Animal Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Alvotech has a net margin of 11.26% compared to Elanco Animal Health's net margin of 9.68%. Elanco Animal Health's return on equity of 7.04% beat Alvotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Alvotech11.26% -38.36% 9.28%
Elanco Animal Health 9.68%7.04%3.45%

Summary

Elanco Animal Health beats Alvotech on 11 of the 17 factors compared between the two stocks.

Get Alvotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALVO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALVO vs. The Competition

MetricAlvotechMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.63B$3.44B$6.21B$10.54B
Dividend YieldN/A2.28%5.70%4.81%
P/E Ratio37.9123.1685.7027.13
Price / Sales5.34448.62581.43177.30
Price / CashN/A46.9237.1060.81
Price / Book-6.3610.4112.236.52
Net Income-$231.86M-$52.77M$3.33B$276.93M
7 Day Performance5.83%2.31%1.17%1.93%
1 Month Performance10.66%12.59%6.85%2.19%
1 Year Performance-29.34%11.18%58.93%34.62%

Alvotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ALVO
Alvotech
3.71 of 5 stars
$8.72
-0.3%
$14.00
+60.6%
-29.3%$2.63B$491.98M37.911,032Analyst Forecast
ELAN
Elanco Animal Health
2.5761 of 5 stars
$20.04
+1.4%
$19.14
-4.5%
+65.2%$9.82B$4.44B23.309,000News Coverage
Analyst Revision
VRNA
Verona Pharma PLC American Depositary Share
1.5429 of 5 stars
$106.91
flat
$109.00
+2.0%
N/A$9.21B$42.28M-107.9930Positive News
RVMD
Revolution Medicines
4.4105 of 5 stars
$48.75
+1.1%
$74.64
+53.1%
+7.3%$9.02B$11.58M-10.83250News Coverage
Analyst Forecast
Insider Trade
Gap Up
ABVX
Abivax
3.4891 of 5 stars
$95.63
+2.0%
$114.25
+19.5%
+787.4%$7.30BN/A0.0061Short Interest ↓
RNA
Avidity Biosciences
2.5512 of 5 stars
$48.96
-1.6%
$68.32
+39.5%
-5.1%$7.26B$10.90M-13.75190News Coverage
Insider Trade
CYTK
Cytokinetics
3.8472 of 5 stars
$59.59
-0.7%
$76.64
+28.6%
+6.3%$7.18B$18.47M-11.68250Trending News
Insider Trade
MRUS
Merus
1.3958 of 5 stars
$94.85
+0.5%
$93.12
-1.8%
+80.1%$7.14B$36.13M-17.2537Short Interest ↓
RYTM
Rhythm Pharmaceuticals
2.874 of 5 stars
$100.77
0.0%
$106.64
+5.8%
+116.9%$6.70B$130.13M-33.48140News Coverage
Analyst Forecast
CRSP
CRISPR Therapeutics
2.2308 of 5 stars
$68.29
-6.5%
$71.71
+5.0%
+41.4%$6.65B$37.31M-12.58460Trending News
Analyst Forecast
Insider Trade
Analyst Revision
GRFS
Grifols
3.7479 of 5 stars
$9.45
+1.4%
$10.30
+9.0%
+11.6%$6.41B$7.81B8.0823,822

Related Companies and Tools


This page (NASDAQ:ALVO) was last updated on 10/19/2025 by MarketBeat.com Staff
From Our Partners